MedPath

A Comparison of Remifentanil Patient-Controlled Analgesia vs. Oral Morphine Analgesia for Dressing Changes in Burns Patients.

Phase 1
Conditions
Pain experienced by patients with pre-existing burns presenting to the burns outpatients unit requiring two or more dressing changes
Registration Number
EUCTR2008-007322-19-GB
Lead Sponsor
Queen Victoria Hospital NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
58
Inclusion Criteria

•Outpatients requiring two or more dressing changes for burns who would normally be considered appropriate for oral morphine analgesia.
•ASA 1 and 2 patients over the age of 18 years

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Patients unable to use the hand control of the PCA device
•Patients who are unable to give full consent or do not agree to participate in the trial
•Hypersensitivity or history of serious adverse reactions to remifentanil or morphine
•Surgical or anaesthetic objections
•Pregnancy

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To determine whether remifentanil PCA or oral morphine provides more effective analgesia for out-patient dressing changes in the burns unit.<br>;Secondary Objective: To determine if burns patients prefer traditional analgesia or remifentanil analgesia for dressing changes ;Primary end point(s): Maximum visual analogue scale (VAS) pain score during the dressing change procedure.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath